Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Unipex Group takes over Debro Pharma
The acquisition of Debro Pharma will expand Unipex Solutions Canada’s product offering to pharmaceutical manufacturers in Canada and the US. Following acquisition, Debro Pharma will continue to operate
The acquisition of Debro Pharma will expand Unipex Solutions Canada’s product offering to pharmaceutical manufacturers in Canada and the US. Following acquisition, Debro Pharma will continue to operate
The Nigeria facility is expected to begin production from first quarter of 2013,The Economic Times reports. The manufacturing capacity of the Nigerian facility will range from 14 million
JHS will manufacture Cardiolite (Kit for the Preparation of Technetium Tc99m Sestamibi for Injection) products and Neurolite (Kit for the Preparation of Technetium Tc99m Bicisate for Injection) under
The project being funded by IAVI’s Innovation Fund will integrate the specialized design capabilities of GMI, the novel biomolecular simulation technology of G&D with the vaccine design expertise
Under the terms of the agreement, Hanmi acquired regional marketing rights for Korea and China and will make an upfront payment, development and sales milestones, and royalties on
As measured by the Montgomery-Asberg Depression Rating Scale, the bipolar I depression patients treated with Latuda experienced statistically significant improvements in symptoms of depression compared to patients taking
The grant will support R&D expenses for the 12-month period from October 2011 through September 2012 to advance research of the Biopump platform technology in a number of
The study will be conducted in 124 patients with CTCL, including those with primary cutaneous anaplastic large cell lymphoma (pcALCL) or mycosis fungoides (MF). The overall response rate,
Xarelto is presently under review with the FDA to reduce the risk of secondary cardiovascular events in patients with ACS. The filing is supported by data from the
As per the agreement, GeneSeek gained certain non-exclusive rights to a number of GTG patents relating to its non-coding DNA technology. The other terms of the agreement have